Skip to main content
Fig. 1 | BMC Public Health

Fig. 1

From: Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysis

Fig. 1

Cohort of asylum seekers in Germany 2017-2019. Blue bars show asylum seekers’ countries of origin by estimated TB incidence; dashed vertical lines show the country-of-origin TB incidence thresholds investigated in this study above which asylum seekers would be eligible for latent TB infection (LTBI) screening; At a TB incidence threshold X, asylum seekers are eligible for screening and treatment of LTBI if their country of origin’s estimate of TB incidence exceeds the threshold X TB cases per 100,000 population. The red line shows cumulative percentages of asylum seekers who would be eligible for LTBI screening at a given incidence threshold.

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us